Tekla Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.6M | Hold |
150,921
| – | – | 0.1% | 105 |
|
|
2023
Q1 | $2.5M | Buy |
+150,921
| New | +$2.5M | 0.1% | 112 |
|
|
2021
Q3 | – | Sell |
-188,767
| Closed | -$11.5M | – | 176 |
|
|
2021
Q2 | $11.5M | Buy |
188,767
+114,053
| +153% | +$6.95M | 0.37% | 71 |
|
|
2021
Q1 | $4.6M | Buy |
+74,714
| New | +$4.6M | 0.16% | 122 |
|
|
2020
Q3 | – | Sell |
-39,228
| Closed | -$1.28M | – | 207 |
|
|
2020
Q2 | $1.28M | Hold |
39,228
| – | – | 0.05% | 186 |
|
|
2020
Q1 | $1.14M | Hold |
39,228
| – | – | 0.05% | 170 |
|
|
2019
Q4 | $1.38M | Buy |
+39,228
| New | +$1.38M | 0.05% | 171 |
|